Lrig1-expression confers suppressive function to CD4<sup>+</sup> cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37666819.
- Also identified by DOI 10.1038/s41467-023-40986-4 and PMC identifier 10477202.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Regulatory T cells (T<sub>reg</sub>) are CD4<sup>+</sup> T cells with immune-suppressive function, which is defined by Foxp3 expression. However, the molecular determinants defining the suppressive population of T cells have yet to be discovered. Here we report that the cell surface protein Lrig1 is enriched in suppressive T cells and controls their suppressive behaviors. Within CD4<sup>+</sup> T cells, T<sub>reg</sub> cells express the highest levels of Lrig1, and the expression level is further increasing with activation. The Lrig1<sup>+</sup> subpopulation from T helper (Th) 17 cells showed higher suppressive activity than the Lrig1<sup>-</sup> subpopulation. Lrig1-deficiency impairs the suppressive function of T<sub>reg</sub> cells, while Lrig1-deficient naïve T cells normally differentiate into other T cell subsets. Adoptive transfer of CD4<sup>+</sup>Lrig1<sup>+</sup> T cells alleviates autoimmune symptoms in colitis and lupus nephritis mouse models. A monoclonal anti-Lrig1 antibody significantly improves the symptoms of experimental autoimmune encephalomyelitis. In conclusion, Lrig1 is an important regulator of suppressive T cell function and an exploitable target for treating autoimmune conditions.
Medical subject headings
- Autoimmunity
- Colitis